Steroidal alkaloids from the bulbs of Fritillaria puqiensis

Journal of Natural Products

Volumn 68, Issue 2, 2005, Pages 264-267

  Jiang, Yan ^a   Li, Huijun ^a   Li, Ping ^a   Cai, Zhaohui ^a   Ye, Wencai ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AMMONIA; ANTITUSSIVE AGENT; NORPUQIETINONE; PUQIENINE A; PUQIENINE B; PUQIETINONOSIDE; STEROID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; COUGHING; DRUG ISOLATION; DRUG SCREENING; FRITILLARIA PUQIENSIS; HUMAN; HUMAN CELL; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT BULB; STRUCTURE ACTIVITY RELATION;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTITUSSIVE AGENTS; CHINA; CRYSTALLOGRAPHY, X-RAY; FRITILLARIA; HUMANS; MICE; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PLANT ROOTS; PLANTS, MEDICINAL; STEROIDS; TUMOR CELLS, CULTURED;

EID: 14544273310     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0497649     Document Type: Article

References (15)

1. The Committee of China Materia Medica. China Materia Medica; Shanghai Scientific and Technological Press: Shanghai, 1999; Vol. 8, pp 7169-7174.
2. Li, P.; Ji, H.; Xu, G. J.; Xu, L. S. J. China Pharm. Univ. 1993, 24, 360-362.
3. Yao, L. N.; Sun, H. Q.; Jiang, Z.; Wei, Y. D.; Lu, C. B. Acta Univ. Med. Tongji. 1993, 22, 47-49.
4. Yu, G. D.; Li, P.; Xu, G. J.; Lu, Y. Q. J. Nanjing Coll. Pharm. 1985, 16, 25-32.
5. Li, P.; Li, X. G.; Xu, G. J.; Kaneko, K. J. China Pharm. Univ. 1990, 21, 198-200.
6. Lin, G.; Ho, Y.-P.; Li, P.; Li, X. G. J. Nat. Prod. 1995, 58, 1662-1667.
7. Ji, H.; Li, P.; Yao, L.; Zhou, S.; Xu, G. J. J. China Pharm. Univ. 1993, 24, 95-97.
8. Li, P.; Wang, Y. X.; Xu, G. J.; Xu, L. S. J. Chin Pharm. Sci. 1995, 4, 217-219.
9. Xu, D. M.; Xu, M. L.; Wang, S. Q.; Hung, E. X.; Wen, X. G. J. Nat. Prod. 1990, 53, 549-552.
10. Li, Q. H.; Wu, Z. H.; Zhang, L. L.; Shao, L. Acta Pharm. Sin. 1988, 23, 415-421.
11. Crystallographic data (excluding structure factors) for compound 1 have been deposited with the Cambridge Crystallographic Data Centre and allocated the deposition number CCDC 242451. Copies of the data can be obtained, free of charge, on application to the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
12. Sheldrick, G. SHELXTL, version 5.1; Bruker Analytical X-ray Systems: Madison, WI, 1997. SHELXS (a structure solution program via Patterson or direct methods) and SHELXL (structure refinement software).
13. Xu, S. Y.; Bian, R. L.; Chen, X. Pharmacological Experiment Methodology; People's Medical Publishing House: Beijing, 1991; p 1167.
14. Ekwall, B.; Johanson, A. Toxicol. Lett. 1980, 5, 299-307.
15. Verlag: C. W.; Ekwall, B. Toxicol. Lett. 1980, 5, 309-317.